Trials / Unknown
UnknownNCT03491956
Double Filtration Plasmapheresis (DFPP) and Lipid Metabolism
Double Filtration Plasmapheresis (DFPP) Improves Lipid Profile and Platelet Function in Hyperlipidemia Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Shanghai Pudong Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Little clinic trials showed that Double Filtration Plasmapheresis (DFPP) could improve lipid metabolism, however, whether DFPP can improve platelet function and recover Endothelial function is unknown. In this study, we try to confirm the hypothesis that DFPP can improve endothelial function in hyperlipidemia patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DFPP | Lipid levels,platelet function，and platelet RNA sequencing in hyperlipidemia patients before and after DFPP |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2018-04-09
- Last updated
- 2021-03-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03491956. Inclusion in this directory is not an endorsement.